Unknown NA INTERVENTIONAL 1-arm NCT03581656

ChordArt System for Mitral Regurgitation (CHAGALL)

ChordArt System Study for the Treatment of Mitral Regurgitation Due to Leaflet Prolapse or Flail

Sponsor: CoreMedic GmbH

Conditions Mitral Regurgitation Mitral Valve Insufficiency Mitral Valve Repair

Updated 7 times since 2018 Last updated: Jul 9, 2022 Started: Mar 21, 2018 Primary completion: Sep 10, 2023 Completion: Dec 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Mitral Regurgitation and Mitral Valve Insufficiency, this trial is ongoing. The trial is conducted by CoreMedic GmbH and has accumulated 7 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Aug 2024 — Sep 2024 [monthly]

Unknown NA

Status: Active Not Recruiting → Unknown
Jul 2024 — Aug 2024 [monthly]

Active Not Recruiting NA
Sep 2022 — Jul 2024 [monthly]

Active Not Recruiting NA
Jan 2021 — Sep 2022 [monthly]

Active Not Recruiting NA

▶ Show 2 earlier versions

Aug 2020 — Jan 2021 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Aug 2018 — Aug 2020 [monthly]

Recruiting NA

First recorded

Mar 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CoreMedic GmbH
Meditrial Europe Ltd.

Data source: CoreMedic GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vilnius, Lithuania